L

LivaNova PLC
D

LIVN

46.750
USD
-0.26
(-0.55%)
مفتوح الان
حجم التداول
2,046
الربح لكل سهم
2
العائد الربحي
-
P/E
109
حجم السوق
2,539,107,045
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABT
    ABT
    0.380
    (0.33%)
    114.790 USD
    BDX
    BDX
    -0.430
    (-0.19%)
    226.020 USD
    BSX
    BSX
    0.875
    (0.97%)
    90.740 USD
    COO
    COO
    -0.320
    (-0.35%)
    92.160 USD
    EW
    EW
    0.100
    (0.13%)
    74.920 USD
    ISRG
    ISRG
    8.16
    (1.55%)
    535.49 USD
    MDT
    MDT
    0.260
    (0.32%)
    81.760 USD
    SYK
    SYK
    2.83
    (0.77%)
    369.88 USD
    TMO
    TMO
    1.45
    (0.28%)
    527.81 USD
    ZBH
    ZBH
    0.120
    (0.11%)
    106.930 USD
    المزيد
الأخبار
المقالات

العنوان: LivaNova PLC

القطاع: Healthcare
الصناعة: Medical Devices
UK-based LivaNova was born of a combination between Cyberonics in the us and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management and heart valve businesses. It derives roughly half of its revenue from the us market, another 21% from Europe, and the remainder from the rest of the world.